Status:
UNKNOWN
Cost-effectiveness of a Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care
Lead Sponsor:
Instituto de Investigación Marqués de Valdecilla
Conditions:
Emotional Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of this study is to test the cost-effectiveness and cost-utility of adding a transdiagnostic group cognitive-behavioural therapy (TD-CBT) to treatment as usual (TAU) for emotional disorders in...
Eligibility Criteria
Inclusion
- Patients aged 18 to 65, inclusive, who present to the PC centre seeking treatment for anxiety, depressive or somatic symptoms.
- Scores above the predetermined cut-off points on the GAD-7 (\>= 10), the PHQ-9 (\>= 10) or the PHQ-15 (\>=10 plus a score of 2 in three or more somatic symptoms).
- Agreement to participate in the study, with written informed consent.
Exclusion
- Major depressive disorder (PHQ-9\> 24) and/or severe disability (SDS \> 25) will be interviewed by a clinician for the presence of any severe mental disorder, including autism spectrum disorders, bipolar disorder, schizophrenia, anorexia nervosa, substance dependence, personality disorder.
- Presence of severe or recent suicide attempts
- Presence of intellectual disability (IQ \< 70).
- Be receiving psychological treatment or any type of specialized care related to mental health.
- Insufficient Spanish language skills
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05314920
Start Date
January 1 2020
End Date
June 1 2023
Last Update
May 20 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Sanitario "Sardinero"
Santander, Spain, 39005
2
Centro Sanitario "Dávila"
Santander, Spain, 39006
3
Centro Sanitario "Camargo Costa"
Santander, Spain, 39600
4
Centro Sanitario "Camargo Interior"
Santander, Spain, 39600